{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.12","upperLimit":"47.9","value":"21.5"}]}],"title":"At time of bone marrow harvest"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"38.2","value":"14.4"}]}],"title":"Day 60 post-transplant"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"7","upperLimit":"53","value":"23.4"}]}],"title":"Day 180 post-transplant"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"49.7","value":"20.1"}]}],"title":"Day 360 post-transplant"}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"}],"units":"Participants"}],"description":"CRM-197 Prevnar-specific vaccine responses that measure the T-cell response of the vaccine quantified as %CD3+/CFSE-low/IFN-gamma+.","dispersionType":"Full Range","groups":[{"description":"therapeutic autologous lymphocytes\n\ntherapeutic tumor infiltrating lymphocytes\n\nmelphalan\n\nautologous hematopoietic stem cell transplantation","id":"OG000","title":"MILs in Patients Undergoing an Autologous Peripheral SCT"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"At time of bone marrow harvest, Day 60 post-transplant, Day 180 post-transplant, and Day 360 post-transplant","title":"Pneumococcal-specific Vaccine Responses","type":"SECONDARY","unitOfMeasure":"%CD3+/CFSE-low/IFN-gamma+"}